Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) were up 50% during mid-day trading on Wednesday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares were traded during trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Stock Performance
The company has a market cap of C$13.95 million, a PE ratio of -10.00 and a beta of 0.32. The company’s 50 day moving average price is C$0.07 and its 200-day moving average price is C$0.06. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- What Investors Need to Know About Upcoming IPOs
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
